121 related articles for article (PubMed ID: 20198277)
1. [Positron emission tomography 2008 in Germany - results of the query and current status].
Kotzerke J; Oehme L; Lindner O; Hellwig D;
Nuklearmedizin; 2010; 49(2):58-64. PubMed ID: 20198277
[TBL] [Abstract][Full Text] [Related]
2. [Positron emission tomography 2013 in Germany. Results of the query and current status].
Kotzerke J; Oehme L; Grosse J; Hellwig D;
Nuklearmedizin; 2015; 54(2):53-9. PubMed ID: 25650552
[TBL] [Abstract][Full Text] [Related]
3. Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter study.
Stergar H; Bockisch A; Eschmann SM; Krause BJ; Rödel R; Tiling R; Weckesser M
Nuklearmedizin; 2007; 46(2):57-64. PubMed ID: 17393040
[TBL] [Abstract][Full Text] [Related]
4. [Current trends in using PET radiopharmaceuticals for diagnostics in oncology].
Adam J; Kadeřávek J; Kužel F; Vašina J; Rehák Z
Klin Onkol; 2014; 27 Suppl 1():S129-36. PubMed ID: 24945550
[TBL] [Abstract][Full Text] [Related]
5. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
6. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
7. [The PET, Past and Future].
Fujii H
Igaku Butsuri; 2015; 35(1):2-9. PubMed ID: 26753390
[TBL] [Abstract][Full Text] [Related]
8. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
9. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
11. PET and PET-CT. State of the art and future prospects.
Fanti S; Franchi R; Battista G; Monetti N; Canini R
Radiol Med; 2005; 110(1-2):1-15. PubMed ID: 16163136
[TBL] [Abstract][Full Text] [Related]
12. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
13. Clinical indications for Gallium-68 positron emission tomography imaging.
Khan MU; Khan S; El-Refaie S; Win Z; Rubello D; Al-Nahhas A
Eur J Surg Oncol; 2009 Jun; 35(6):561-7. PubMed ID: 19201567
[TBL] [Abstract][Full Text] [Related]
14. [Quality control of outpatient imaging examinations in North Rhine-Westphalia, Part II].
Krug B; Boettge M; Reineke T; Coburger S; Zähringer M; Harnischmacher U; Lüngen M; Lauterbach KW; Lehmacher W; Lackner K
Rofo; 2003 Mar; 175(3):346-60. PubMed ID: 12635011
[TBL] [Abstract][Full Text] [Related]
15. PET and PET/CT in endocrine tumours.
Dudczak R; Traub-Weidinger T
Eur J Radiol; 2010 Mar; 73(3):481-93. PubMed ID: 20089377
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/computed tomography.
Townsend DW
Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
18. [The status of domestic PET/CT attendance in the light of the waiting list data].
Galuska L; Balkay L
Magy Onkol; 2010 Jun; 54(2):161-8. PubMed ID: 20576593
[TBL] [Abstract][Full Text] [Related]
19. [Myocardial perfusion scintigraphy in Germany. Results of the 2005 query and current status].
Lindner O; Burchert W; Bengel FM; Zimmermann R; Vom Dahl J; Schäfer W; Büll U; Schober O; Schwaiger M; Kluge R; Schäfers M;
Nuklearmedizin; 2007; 46(2):49-55. PubMed ID: 17393039
[TBL] [Abstract][Full Text] [Related]
20. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
Ann Nucl Med; 2007 Nov; 21(9):481-98. PubMed ID: 18030580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
